About this Research Topic
Even after significant advances and heavy investment in cardiovascular disease [CVD] research and technology, CVD remains the leading cause of death in women. The current guidelines for treating women for cardiovascular disease are the same as those for men, despite overwhelming evidence reported over years of clinical research showing significant sex differences in the pathophysiology of CVD.
This special issue of Frontiers in Reproductive Health – Menopause, calls for papers that promote recognition, increase overall knowledge and stimulate research on the specific and unique effect of the menopause transition and the early initiation of hormone therapy on cardiovascular disease progression.
Submissions of studies and literature reviews covering the following topics will be solicited:
1. Increase in CVD in women during the menopause transition and perimenopause.
2. Increase in CVD risk factors in women during the menopause transition and perimenopause.
3. Risks and benefits of hormone replacement treatment options in women when initiated prior to the menopause transition, during the transition, or after the transition.
4. Risks and benefits of MHT during the menopause transition or the perimenopause for various treatment durations.
5. Risks and benefits of standard CVD prevention medications when given to women during the menopause transition or perimenopause.
6. Risks and benefits of dietary, exercise, or over-the-counter interventions in women during the menopause transition or perimenopause.
7. Risks and benefits of dietary, exercise, over-the counter interventions, and standard treatment regimens when given with and without addition of hormone replacement therapy.
8. Risks and benefits of CVD prevention treatment protocols in women during the menopause transition comparing with estrogen use versus no estrogen use.
9. Define new cardiovascular risk factors that substantially change during the menopause transition.
10. Papers discussing educational or advertisement ideas for getting scientific information on the importance of the menopause transition on CVD risk and the benefits of hormone replacement therapy.
11. Risks and benefits of addition of testosterone replacement in perimenopausal or menopausal women and its impact on cardiovascular disease.
This special issue of Frontiers in Reproductive Health – Menopause, calls for papers that promote recognition, increase overall knowledge and stimulate research on the specific and unique effect of the menopause transition and the early initiation of hormone therapy on cardiovascular disease progression.
Submissions of studies and literature reviews covering the following topics will be solicited:
1. Increase in CVD in women during the menopause transition and perimenopause.
2. Increase in CVD risk factors in women during the menopause transition and perimenopause.
3. Risks and benefits of hormone replacement treatment options in women when initiated prior to the menopause transition, during the transition, or after the transition.
4. Risks and benefits of MHT during the menopause transition or the perimenopause for various treatment durations.
5. Risks and benefits of standard CVD prevention medications when given to women during the menopause transition or perimenopause.
6. Risks and benefits of dietary, exercise, or over-the-counter interventions in women during the menopause transition or perimenopause.
7. Risks and benefits of dietary, exercise, over-the counter interventions, and standard treatment regimens when given with and without addition of hormone replacement therapy.
8. Risks and benefits of CVD prevention treatment protocols in women during the menopause transition comparing with estrogen use versus no estrogen use.
9. Define new cardiovascular risk factors that substantially change during the menopause transition.
10. Papers discussing educational or advertisement ideas for getting scientific information on the importance of the menopause transition on CVD risk and the benefits of hormone replacement therapy.
11. Risks and benefits of addition of testosterone replacement in perimenopausal or menopausal women and its impact on cardiovascular disease.
Keywords: menopause, CVD, cardiovascular disease, women, perimenopause, menopause transition
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
